共 25 条
- [1] 1.6 Exenatide BID vs. Insulin Lispro TIDM Added to Titrated Insulin Glargine QD in Metformin-Treated T2DM Patients Resulted in Similar Glycemic Control but Weight Loss and Less Hypoglycemia: The 4B Study (70-OR)[J]. Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 79 - 79Michaela DiamantMichael NauckRimma ShaginianJames MaloneSimon CleallDaniëlle de VriesByron J. HoogwerfLeigh MacconellBruce Wolffenbuttel
- [2] Glycaemic control and hypoglycaemia in metformin-treated T2DM patients with exenatide BID vs insulin lispro TID added to titrated insulin glargine QD: the 4B trial[J]. DIABETOLOGIA, 2013, 56 : S7 - S7Wolffenbuttel, B. H. R.Nauck, M. A.Shaginian, R.Malone, J.Cleall, S.de Vries, D.Hoogwerf, B.MacConell, L.Diamant, M.
- [3] Impact on cardiovascular risk factors of exenatide BID vs insulin lispro TID added to titrated insulin glargine QD in metformin-treated type 2 diabetes mellitus patients: the 4B trial[J]. DIABETOLOGIA, 2013, 56 : S393 - S394Diamant, M.Nauck, M. A.Shaginian, R.Malone, J.Cleall, S.de Vries, D.Hoogwerf, B.MacConell, L.Wolffenbuttel, B. H. R.
- [4] The Relationship of Recurrent Hypoglycemia with Glycemic Control and Insulin Change in Patients Treated with Insulin Glargine and Exenatide Twice Daily vs. Insulin Lispro or Placebo[J]. DIABETES, 2015, 64 : A645 - A645Strand, JormaGouet, DidierHan, JennyRuggles, JamesZhuplatov, Sergey
- [5] Less hypoglycemia with exenatide versus insulin glargine, despite similar Hba1c improvement, in patients with T2dm adjunctively treated with metformin[J]. DIABETES, 2007, 56 : A45 - A45Trautmann, MichaelBurger, JudeJohns, DonBrodows, RobertOkerson, TedRoberts, AnthonyBarnett, Anthony
- [6] Once-Weekly GLP-1 Receptor Agonist Albiglutide vs. Titrated Prandial Lispro Added on to Titrated Basal Insulin Glargine in Type 2 Diabetes (T2D) Uncontrolled on Glargine Plus Oral Agents: Similar Glycemic Control With Weight Loss and Less Hypoglycemia[J]. DIABETES, 2012, 61 : A15 - A16Rosenstock, JulioAhren, BoChow, FrancisFonseca, VivianGross, JorgeRatner, RobertJohnson, SusanStewart, MurrayYang, FredLeiter, Lawrence
- [7] Optimizing Glycemic Control in T2DM Patients Previously Treated With Intensive Insulin Therapy and Switched to Exenatide-Insulin Glargine Combination[J]. DIABETES, 2013, 62 : A261 - A261Avramidis, IakovosSpyridonidou, ChristinaStoimenis, DimitrisLalia, Antigoni
- [8] Effect of Lixisenatide vs. Liraglutide on Glycemic Control, Gastric Emptying, and Safety Parameters in Optimized Insulin Glargine T2DM ± Metformin[J]. DIABETES, 2014, 63 : A262 - A262Meier, JurisRosenstock, JulioHincelin-Mery, AgnesRoyduval, ChristineDelfolie, AstridCoester, Hans-VeitForst, ThomasKapitza, Christoph
- [9] Comparison of exenatide and insulin glargine in MET and SU-treated patients with type 2 diabetes: Exenatide achieved equivalent glycemic control, with weight reduction and less nocturnal hypoglycemia[J]. DIABETES, 2005, 54 : A3 - A3Heine, RJVan Gaal, LFJohns, DMihm, MJWidel, MHBrodows, RG
- [10] Effects of Exenatide vs. Insulin Aspart on Glycemic Control and Hypoglycemia in Diabetes Patients Treated with Metformin: Primary Results of a Randomized, Open-Label Study[J]. DIABETES, 2010, 59 : A152 - A152Gallwitz, BaptistBoehmer, MichaelSegiet, ThomasMoelle, AndreaMilek, KarstenBecker, BerndHelsberg, KarinPetto, HelmutPeters, NatalieBachmann, Oliver